Bayer Intellectual Property GmbH et al v. Torrent Pharmaceuticals, Limited et al > Summary
Court Case Number 1:17-cv-01163
Filing Date Aug 18, 2017
Termination Date Dec 22, 2020
Court Delaware District Court
Status Statistical Closing
JudgesRichard G. Andrews
Plaintiff Attorneys
31Bayer Intellectual Property GmbH
Attorney Name: Derek J. Fahnestock
Morris Nichols Arsht & Tunnell
Bayer Intellectual Property GmbH
Attorney Name: Rodger D. Smith II
Morris Nichols Arsht & Tunnell
BAYER SAS
Attorney Name: Jack B. Blumenfeld
Morris Nichols Arsht & Tunnell
BAYER SAS
Attorney Name: Derek J. Fahnestock
Morris Nichols Arsht & Tunnell
BAYER SAS
Attorney Name: Rodger D. Smith II
Morris Nichols Arsht & Tunnell
JANSSEN PHARMACEUTICALS (Johnson & Johnson)
Attorney Name: Jack B. Blumenfeld
Morris Nichols Arsht & Tunnell
JANSSEN PHARMACEUTICALS (Johnson & Johnson)
Attorney Name: Derek J. Fahnestock
Morris Nichols Arsht & Tunnell
JANSSEN PHARMACEUTICALS (Johnson & Johnson)
Attorney Name: Rodger D. Smith II
Morris Nichols Arsht & Tunnell
Bayer Corporation
Attorney Name: Rodger D. Smith II
Morris Nichols Arsht & Tunnell
Bayer Corporation
Attorney Name: Adam L. Perlman
Williams & Connolly
Bayer Corporation
Attorney Name: Dov P. Grossman
Williams & Connolly
Bayer Corporation
Attorney Name: Alexander S. Zolan
Williams & Connolly
Bayer Corporation
Attorney Name: Martha C. Kidd
Williams & Connolly
Bayer Intellectual Property GmbH
Attorney Name: Kathryn S. Kayali
Williams & Connolly
Bayer Corporation
Attorney Name: David Pritikin
Sidley Austin
Bayer Corporation
Attorney Name: Lisa A. Schneider
Sidley Austin
Bayer Corporation
Attorney Name: Bindu Donovan
Sidley Austin
Bayer Corporation
Attorney Name: S. Isaac Olson
Sidley Austin
Bayer Intellectual Property GmbH
Attorney Name: Adam L. Perlman
Williams & Connolly
Bayer Intellectual Property GmbH
Attorney Name: Dov P. Grossman
Williams & Connolly
Bayer Intellectual Property GmbH
Attorney Name: Alexander S. Zolan
Williams & Connolly
Bayer Intellectual Property GmbH
Attorney Name: Martha C. Kidd
Williams & Connolly
Bayer Corporation
Attorney Name: Kathryn S. Kayali
Williams & Connolly
Bayer Intellectual Property GmbH
Attorney Name: David Pritikin
Sidley Austin
Bayer Intellectual Property GmbH
Attorney Name: Lisa A. Schneider
Sidley Austin
Bayer Intellectual Property GmbH
Attorney Name: Bindu Donovan
Sidley Austin
Bayer Intellectual Property GmbH
Attorney Name: S. Isaac Olson
Sidley Austin
Bayer Corporation
Attorney Name: Bruce R. Genderson
Williams & Connolly
BAYER SAS
Attorney Name: Todd L. Krause
Sidley Austin
Attorney Name: Todd L. Krause
Defendant Attorneys
7Torrent Pharma Inc.
Attorney Name: Pilar G. Kraman
Young Conaway Stargatt & Taylor
Torrent Pharmaceuticals
Attorney Name: Cedric Cy Tan
Pillsbury Winthrop Shaw Pittman
Torrent Pharmaceuticals
Attorney Name: Alton L. Hare III
Pillsbury Winthrop Shaw Pittman
Torrent Pharmaceuticals
Attorney Name: Keeto Sabharwal
Pillsbury Winthrop Shaw Pittman
Attorney Name: Alton L. Hare III
Attorney Name: Michelle A. Herrera
Counter Defendant
9BAYER SAS
Attorney Name: Jack B. Blumenfeld
Morris Nichols Arsht & Tunnell
BAYER SAS
Attorney Name: Derek J. Fahnestock
Morris Nichols Arsht & Tunnell
BAYER SAS
Attorney Name: Rodger D. Smith II
Morris Nichols Arsht & Tunnell
Bayer Intellectual Property GmbH
Attorney Name: Jack B. Blumenfeld
Morris Nichols Arsht & Tunnell
Bayer Intellectual Property GmbH
Attorney Name: Derek J. Fahnestock
Morris Nichols Arsht & Tunnell
Bayer Intellectual Property GmbH
Attorney Name: Rodger D. Smith II
Morris Nichols Arsht & Tunnell
JANSSEN PHARMACEUTICALS (Johnson & Johnson)
Attorney Name: Jack B. Blumenfeld
Morris Nichols Arsht & Tunnell
JANSSEN PHARMACEUTICALS (Johnson & Johnson)
Attorney Name: Derek J. Fahnestock
Morris Nichols Arsht & Tunnell
JANSSEN PHARMACEUTICALS (Johnson & Johnson)
Attorney Name: Rodger D. Smith II
Morris Nichols Arsht & Tunnell
Counter Claimant
2Cause
35:271 Patent Infringement
Related Patents
| Doc No | Title | Issue date |
|---|---|---|
| 09597397 | Formulations of bendamustine | Mar 21, 2017 |
| 09597398 | Formulations of bendamustine | Mar 21, 2017 |
| 09597399 | Formulations of bendamustine | Mar 21, 2017 |
| 09579384 | Method of treating bendamustine-responsive conditions in patients requiring reduced volumes for administration | Feb 28, 2017 |
| 09572796 | Formulations of bendamustine | Feb 21, 2017 |
| 09572797 | Formulations of bendamustine | Feb 21, 2017 |
| 09572887 | Formulations of bendamustine | Feb 21, 2017 |
| 09539218 | Prevention and treatment of thromboembolic disorders | Jan 10, 2017 |
| 09265831 | Formulations of bendamustine | Feb 23, 2016 |
| 09144568 | Formulations of bendamustine | Sep 29, 2015 |
| 09034908 | Formulations of bendamustine | May 19, 2015 |
| 09000021 | Method of treating bendamustine-responsive conditions in patients requiring reduced volumes for administration | Apr 7, 2015 |
| 08791270 | Bendamustine pharmaceutical compositions | Jul 29, 2014 |
| 08609707 | Formulations of bendamustine | Dec 17, 2013 |
